It was learned from Dalian Changxing Island Economic Zone Network that on November 1, the Changxing Island Economic Zone Management Committee and Jiangsu Changzhou Sunshine Pharmaceutical Co.
signed a letter of intent for project investment cooperation, with a total investment of 500 million yuan for high-end polyimide monomers and The project of an integrated base for the production and development of pharmaceutical intermediate products has officially settled in Changxing Island
According to reports, after preliminary negotiation, Changzhou Sunshine Pharmaceutical Co.
and Shanghai Huayi Group Investment Co.
jointly invested and established a project company to build an integrated base project for the production and development of high-end polyimide monomers and pharmaceutical intermediates
The total investment of the project is about 500 million yuan.
It is planned to be located in Changxing Island Fine Chemical Innovation Park, and the construction will be completed in two phases